These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7922207)

  • 1. Glomerulonephritis.
    Remuzzi G; Zoja C; Bertani T
    Curr Opin Nephrol Hypertens; 1993 May; 2(3):465-74. PubMed ID: 7922207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of glomerular damage in glomerulonephritis.
    Couser WG
    Nephrol Dial Transplant; 1998; 13 Suppl 1():10-5. PubMed ID: 9507491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular protein trafficking and progression of renal disease to terminal uremia.
    Benigni A; Remuzzi G
    Semin Nephrol; 1996 May; 16(3):151-9. PubMed ID: 8734458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory.
    Pichler R; Giachelli C; Young B; Alpers CE; Couser WG; Johnson RJ
    Miner Electrolyte Metab; 1995; 21(4-5):317-27. PubMed ID: 7565480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A; Gómez-Chiarri M; Alonso J; Bustos C; Gómez-Guerrero C; López-Armada MJ; Gómez-Garre D; Palacios I; Ruíz-Ortega M; Gutierrez S
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
    J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of macrophages in glomerulonephritis.
    Nikolic-Paterson DJ; Atkins RC
    Nephrol Dial Transplant; 2001; 16 Suppl 5():3-7. PubMed ID: 11509677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The humoral and cellular factors of glomerular damage].
    Camussi G; Montrucchio G
    Ann Ital Med Int; 1992; 7(4):226-33. PubMed ID: 1298333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
    Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
    Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
    Lan HY; Mu W; Yang N; Meinhardt A; Nikolic-Paterson DJ; Ng YY; Bacher M; Atkins RC; Bucala R
    Am J Pathol; 1996 Oct; 149(4):1119-27. PubMed ID: 8863661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
    Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
    Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of tubulointerstitial injury in the early phase of primary glomerular disease.
    Hruby Z; Smolska D; Filipowski H; Rabczyński J; Cieślar E; Kopeć W; Dulawa J
    J Intern Med; 1998 Mar; 243(3):215-22. PubMed ID: 9627159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis.
    Hooke DH; Hancock WW; Gee DC; Kraft N; Atkins RC
    Clin Nephrol; 1984 Oct; 22(4):163-8. PubMed ID: 6391767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?
    Javaid B; Quigg RJ
    Kidney Int; 2005 May; 67(5):1692-703. PubMed ID: 15840015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.